Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:psychotherapy
|
| gptkbp:contraindication |
mild cases without risk factors
|
| gptkbp:goal |
reduce mortality
prevent hospitalization reduce severity |
| gptkbp:includes |
gptkb:baricitinib
gptkb:molnupiravir gptkb:tocilizumab gptkb:dexamethasone gptkb:remdesivir supportive care antiviral drugs oxygen therapy corticosteroids monoclonal antibodies mechanical ventilation convalescent plasma paxlovid |
| gptkbp:monitors |
clinical trials
|
| gptkbp:recommendation |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:National_Institutes_of_Health gptkb:World_Health_Organization |
| gptkbp:treatment |
gptkb:COVID-19
|
| gptkbp:updated |
emerging evidence
|
| gptkbp:bfsParent |
gptkb:FDA
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
COVID-19 treatments
|